Global PEGylated Proteins Market 2012- 2022

March 2017 | 77 pages | ID: GF3ECD7D715EN
HeyReport

Abstracts

SUMMARY

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

By Type

• Colony Stimulating Factors
• Interferons
• Erythropoietin (EPO)
• Recombinant Factor Viii
• Monoclonal Antibodies

Based on region, the report describes major regions market by vendor, products and Application. Regions mentioned as follows:

• Europe
• North America
• China
• Japan & Korea

Based on Application, the report describes major Application share of regional market. Application mentioned as follows:

• Cancer Treatment
• Hepatitis
• Chronic Kidney Disease
• Leukemia
• SCID
• Rheumatoid Arthritis & Crohn's Disease

Leading vendors in the market are included based on sales; price, sales regions, products and profile etc. Vendors mentioned as follows:

• ENZON Pharmaceuticals
• Merck Sharp & Dohme
• Roche
• Pfizer
• Amgen
• UCB
• Crealta (Savient)

Contents

1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Product
    1.2.1.1 Colony Stimulating Factors
    1.2.1.2 Interferons
    1.2.1.3 Erythropoietin (EPO)
    1.2.1.4 Recombinant Factor Viii
    1.2.1.5 Monoclonal Antibodies
  1.2.2 by Application
    1.2.2.1 Cancer Treatment
    1.2.2.2 Hepatitis
    1.2.2.3 Chronic Kidney Disease
    1.2.2.4 Leukemia
    1.2.2.5 SCID
    1.2.2.6 Rheumatoid Arthritis & Crohn's Disease
  1.2.3 by Regions
    1.2.3.1 Europe
    1.2.3.2 North America
    1.2.3.3 China
    1.2.3.4 Japan & Korea

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
  2.2.1 Raw Material
  2.2.2 Major Equipment
  2.2.3 Manufacturing Cost Structure
  2.2.4 Manufacturing Process
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MAJOR VENDORS

4.1 ENZON Pharmaceuticals
  4.1.1 Profile
  4.1.2 Business Performance
4.2 Merck Sharp & Dohme
  4.2.1 Profile
  4.2.2 Business Performance
4.3 Roche
  4.3.1 Profile
  4.3.2 Business Performance
4.4 Pfizer
  4.4.1 Profile
  4.4.2 Business Performance
4.5 Amgen
  4.5.1 Profile
  4.5.2 Business Performance
4.6 UCB
  4.6.1 Profile
  4.6.2 Business Performance
4.7 Crealta (Savient)
  4.7.1 Profile
  4.7.2 Business Performance

5 MARKET/VENDORS DISTRIBUTION

5.1 Regional Distribution
  5.1.1 Headquarters
  5.1.2 Sales Region
5.2 Product and Application
  5.2.1 Product
  5.2.2 Application

6 REGIONS MARKET

6.1 Global
  6.1.1 Overview
  6.1.2 by Vendors
  6.1.3 by Products
  6.1.4 by Application
  6.1.5 by Regions
6.2 Europe
  6.2.1 Overview
  6.2.2 by Vendors
  6.2.3 by Products
  6.2.4 by Application
  6.2.5 by Regions
6.3 North America
  6.3.1 Overview
  6.3.2 by Vendors
  6.3.3 by Products
  6.3.4 by Application
  6.3.5 by Regions
6.4 China
  6.4.1 Overview
  6.4.2 by Vendors
  6.4.3 by Products
  6.4.4 by Application
  6.4.5 by Regions
6.5 Japan & Korea
  6.5.1 Overview
  6.5.2 by Vendors
  6.5.3 by Products
  6.5.4 by Application
  6.5.5 by Regions
6.6 Trade

7 FORECAST

7.1 Market Trends
7.2 Segment Forecast
  7.2.1 by Products
  7.2.2 by Application
  7.2.3 by Regions

8 MARKETING OVERVIEW

8.1 Ex-factory Price
8.2 Buyer Price
8.3 Price Factors
8.4 Marketing Channel

9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Product Specifications of PEGylated Proteins
Table Products Segment of PEGylated Proteins
Table Colony Stimulating Factors Overview
Table Interferons Overview
Table Erythropoietin (EPO) Overview
Table Recombinant Factor Viii Overview
Table Monoclonal Antibodies Overview
Table Application Segment of PEGylated Proteins
Table Cancer Treatment Overview
Table Hepatitis Overview
Table Chronic Kidney Disease Overview
Table Leukemia Overview
Table SCID Overview
Table Rheumatoid Arthritis & Crohn's Disease Overview
Table Raw Material Suppliers Analysis
Table Equipment Suppliers Analysis
Table Market Dynamics
Table Policy of PEGylated Proteins
Table Technology of PEGylated Proteins
Table ENZON Pharmaceuticals Profile List
Table PEGylated Proteins Operating Data of ENZON Pharmaceuticals,2012-2016 (g, USD Million, USD/mg)
Table Merck Sharp & Dohme Profile List
Table PEGylated Proteins Operating Data of Merck Sharp & Dohme,2012-2016 (g, USD Million, USD/mg)
Table Roche Profile List
Table PEGylated Proteins Operating Data of Roche,2012-2016 (g, USD Million, USD/mg)
Table Pfizer Profile List
Table PEGylated Proteins Operating Data of Pfizer,2012-2016 (g, USD Million, USD/mg)
Table Amgen Profile List
Table PEGylated Proteins Operating Data of Amgen,2012-2016 (g, USD Million, USD/mg)
Table UCB Profile List
Table PEGylated Proteins Operating Data of UCB,2012-2016 (g, USD Million, USD/mg)
Table Crealta (Savient) Profile List
Table PEGylated Proteins Operating Data of Crealta (Savient),2012-2016 (g, USD Million, USD/mg)
Table Headquarters of Major Vendors
Table Main Sales Region of Major Vendors
Table Main Product of Major Vendors
Table Main Application of Major Vendors
Table PEGylated Proteins Price of Global, 2012-2016 (USD/mg)
Table PEGylated Proteins Price of Europe, 2012-2016 (USD/mg)
Table PEGylated Proteins Price of North America, 2012-2016 (USD/mg)
Table PEGylated Proteins Price of China, 2012-2016 (USD/mg)
Table PEGylated Proteins Price of Japan & Korea, 2012-2016 (USD/mg)
Table Global Sales Forecast, by Products, (2017-2022, Million USD)
Table Global Sales Forecast, by Application, (2017-2022, Million USD)
Table Global Sales Forecast, by Regions, (2017-2022, Million USD)
Table Price Factors List
Table Part of Interviewees List
Table Part of Source List
Table Methodology of HeyReport Overview

List Of Figures

LIST OF FIGURES

Figure PEGylated Proteins Picture
Figure Colony Stimulating Factors Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Interferons Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Erythropoietin (EPO) Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Recombinant Factor Viii Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Monoclonal Antibodies Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Cancer Treatment Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Hepatitis Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Chronic Kidney Disease Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Leukemia Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure SCID Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Rheumatoid Arthritis & Crohn's Disease Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure China Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Japan & Korea Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Industry Chain Structure of PEGylated Proteins
Figure Manufacturing Process of PEGylated Proteins
Figure SWOT of PEGylated Proteins
Figure GDP of Major Countries
Figure PEGylated Proteins Sales and Growth of Global, 2012-2016 (USD Million)
Figure PEGylated Proteins Sales of Global, by Vendors (2016, USD Million)
Figure PEGylated Proteins Sales of Global, by Products (2016, USD Million)
Figure PEGylated Proteins Sales of Global, by Application (2016, USD Million)
Figure PEGylated Proteins Sales of Global, by Regions (2016, USD Million)
Figure PEGylated Proteins Sales and Growth of Europe, 2012-2016 (USD Million)
Figure PEGylated Proteins Sales of Europe, by Vendors (2016, USD Million)
Figure PEGylated Proteins Sales of Europe, by Products (2016, USD Million)
Figure PEGylated Proteins Sales of Europe, by Application (2016, USD Million)
Figure PEGylated Proteins Sales and Growth of North America, 2012-2016 (USD Million)
Figure PEGylated Proteins Sales of North America, by Vendors (2016, USD Million)
Figure PEGylated Proteins Sales of North America, by Products (2016, USD Million)
Figure PEGylated Proteins Sales of North America, by Application (2016, USD Million)
Figure PEGylated Proteins Sales and Growth of China, 2012-2016 (USD Million)
Figure PEGylated Proteins Sales of China, by Vendors (2016, USD Million)
Figure PEGylated Proteins Sales of China, by Products (2016, USD Million)
Figure PEGylated Proteins Sales of China, by Application (2016, USD Million)
Figure PEGylated Proteins Sales and Growth of Japan & Korea, 2012-2016 (USD Million)
Figure PEGylated Proteins Sales of Japan & Korea, by Vendors (2016, USD Million)
Figure PEGylated Proteins Sales of Japan & Korea, by Products (2016, USD Million)
Figure PEGylated Proteins Sales of Japan & Korea, by Application (2016, USD Million)
Figure World Trade Flows
Figure Global Sales Forecast and Growth, (2017-2022, Million USD)
Figure Marketing Channels Overview